Recombinant plasmid and recombinant bacterium for expressing SARS-CoV-2 N protein, construction method and application
A recombinant plasmid and construction method technology, applied in the field of vaccines, can solve the problems of insufficient activity, loss, difficulty in expression, etc., and achieve the effects of good protein activity, high expression amount, and auxiliary monitoring of infection and outbreak.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0031] The present invention has no special restrictions on the source of the full-length sequence of the N protein. During the specific implementation of the present invention, the full-length sequence of the N protein is preferably prepared by the following method: reverse the RNA genome of the SARS-CoV-2 virus Transcribing to obtain cDNA; using the cDNA as a template, using the third primer and the fourth primer to perform PCR amplification to obtain the full-length sequence of the N protein; the present invention has no special method for preparing the RNA genome of the SARS-CoV-2 virus Restrictions are obtained by conventional methods in the art or conventional virus RNA genome kit extracts; the reverse transcription system is calculated in 20 μl and includes the following components: 5×PrimeScript IV cDNA Synthesis Mix 4 μl, Random 6mers (50 μM) 0~ 2μl, RNA genome of SARS-CoV-2 virus: total RNA≤5μg, poly(A)+RNA≤1μg and the rest of RNase Free dH 2 O; the reverse transcrip...
Embodiment 1
[0067] 1. SARS-Cov-2 total cDNA synthesis reaction
[0068] 1) Refer to the reverse transcription system in Table 1 to prepare the following reaction solution on ice:
[0069] Table 1 Reverse transcription system
[0070]
[0071]
[0072] 2) After mixing gently, react according to the following conditions: 30°C for 10 minutes, 95°C for 5 minutes or inactivate the enzyme, then cool on ice.
[0073] 2. N protein gene amplification
[0074] According to the relevant sequence information published in the GenBank database (genome sequence number is MN908947.3), design viral recombinant nucleoprotein (N protein) gene-specific primers (NP forward primer (third primer) is 5'-ATGTCTGATAATGGACCCCAAAATCAG-3', As shown in SEQ ID NO.3; NP reverse primer (the fourth primer) is 5'-TTAGGCCTGAGTTGAGTCAGCAC-3', as shown in SEQ ID NO.4), and carry out PCR amplification to obtain the full-length sequence of N protein, using The PCR product of the full-length sequence of N protein amplif...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



